Myopic Shift at 10 Years Follow-up in the Infant Aphakia Treatment Study

• Type of Material: Article
• Authors: David R. Weakley Jr., University of Texas Southwestern; Azhar Nizam, Emory University; Deborah K. VanderVeen, Harvard Medical School; M. Edward Wilson, University of South Carolina; Stacy Kruger, Zucker School of Medicine at Hofstra/Northwell Health; Scott R. Lambert, Stanford University School of Medicine
• Language: English
• Date: 2022-04-08
• Publisher: The American Academy of Ophthalmology
• Publication Version: Author Accepted Manuscript (After Peer Review)
• Copyright Statement: © 2022 by the American Academy of Ophthalmology
• License: Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
• Final Published Version (URL): https://doi.org/10.1016%2Fj.ophtha.2022.04.004
• Title of Journal or Parent Work: Ophthalmology
• Volume: 129
• Issue: 9
• Start Page: 1064
• End Page: 1065
• Grant/Funding Information: Supported by National Institutes of Health Grants U10 EY13272 and U10 EY013287 and in part by NIH Departmental Core Grant EY006360 and Research to Prevent Blindness, Inc., New York, New York.
• Keywords: myopic shift; Infant Aphakia Treatment Study; anisometropia
• Research Categories: Health Sciences, Medicine and Surgery; Health Sciences, General

Abstract

We studied the myopic shift and anisometropia at 10.6 (+/−0.3) years of age in the Infant Aphakia Treatment Study. We found myopic shift continues in the operated eye from 5-10.5 years at a lower rate than that prior to age five years while anisometropia increases proportionally.